CGD patients lack p22phox, which is essential for the proper function of the NADPH oxidase Nox1-4, but CGD macrophages showed either no defect in IL-1β release (112), or even an increased caspase-1 activity and IL-1β release (113, 114). Here, FMO5 is linked to chronic granulomatous disease.